Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 369,100,000
  • Shares Outstanding, K 2,000
  • 60-Month Beta 0.88
Trade IHE with:
  • Price/Earnings ttm 29.37
  • Annual Dividend & Yield 2.59 (1.40%)
  • Most Recent Dividend 0.721 on 06/10/21
  • Management Fee 0.42%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 16.49%
  • Historical Volatility 11.71%
  • IV Percentile 15%
  • IV Rank 28.10%
  • IV High 33.25% on 10/30/20
  • IV Low 9.95% on 04/20/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 45
  • Open Int (30-Day) 45

Price Performance

See More
Period Period Low Period High Performance
1-Month
182.33 +2.03%
on 06/02/21
189.58 -1.87%
on 06/10/21
-0.13 (-0.07%)
since 05/21/21
3-Month
172.76 +7.68%
on 03/25/21
189.58 -1.87%
on 06/10/21
+6.51 (+3.63%)
since 03/19/21
52-Week
150.52 +23.59%
on 06/26/20
189.58 -1.87%
on 06/10/21
+31.74 (+20.57%)
since 06/19/20

Most Recent Stories

More News
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 73.02 (+0.66%)
JNJ : 163.79 (+1.12%)
LLY : 221.78 (+1.48%)
CTLT : 109.50 (+0.82%)
PJP : 80.69 (+0.52%)
IHE : 186.18 (+0.82%)
5 Sector ETFs That Survived Last Week's Turmoil

We have highlighted five sector ETFs that performed well last week and survived the broad market rout.

IHE : 186.18 (+0.82%)
RING : 28.81 (+1.80%)
PSCC : 104.51 (+1.04%)
AMJ : 20.11 (+3.55%)
BUG : 28.94 (-0.17%)
Pharma ETFs in Focus Post Q1 Earnings

The slew of Q1 results have led to mixed trading in pharma ETFs over the past month.

PPH : 73.02 (+0.66%)
PJP : 80.69 (+0.52%)
IHE : 186.18 (+0.82%)
XPH : 52.48 (+1.04%)
FTXH : 25.85 (-0.81%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 73.02 (+0.66%)
JNJ : 163.79 (+1.12%)
LLY : 221.78 (+1.48%)
CTLT : 109.50 (+0.82%)
PJP : 80.69 (+0.52%)
IHE : 186.18 (+0.82%)
Healthcare ETFs in Focus Post JNJ's Q1 Earnings Results

Johnson & Johnson (JNJ) continued its long streak of earnings beat and outpaced revenue estimates. However, the company tightened its full-year guidance.

JNJ : 163.79 (+1.12%)
XLV : 124.71 (+0.78%)
VHT : 245.11 (+1.23%)
IYH : 270.31 (+1.14%)
IHE : 186.18 (+0.82%)
IEIH : 34.51 (+0.94%)
Will J&J ETFs Suffer on Latest COVID-19 Vaccine Updates?

Let's take a look at some ETFs that can see adverse impacts as Johnson & Johnson's coronavirus vaccine sees a setback amid the worsening pandemic conditions.

JNJ : 163.79 (+1.12%)
XLV : 124.71 (+0.78%)
IYH : 270.31 (+1.14%)
IHE : 186.18 (+0.82%)
FTXH : 25.85 (-0.81%)
IEIH : 34.51 (+0.94%)
ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.

PFE : 39.40 (+1.52%)
MRNA : 209.45 (+5.15%)
IHE : 186.18 (+0.82%)
FDL : 33.57 (+1.64%)
FTXH : 25.85 (-0.81%)
IEIH : 34.51 (+0.94%)
BNTX : 224.90 (+5.88%)
J&J ETFs to Shine Bright as FDA Grants EUA for Coronavirus Vaccine

Johnson & Johnson's receipt of EUA for its single-shot COVID-19 vaccine will strengthen the U.S. government's position in the fight against the pandemic and benefit ETFs with high exposure to the pharmaceutical...

JNJ : 163.79 (+1.12%)
XLV : 124.71 (+0.78%)
IYH : 270.31 (+1.14%)
IHE : 186.18 (+0.82%)
FTXH : 25.85 (-0.81%)
IEIH : 34.51 (+0.94%)
How to Trade USFDA's EUA to J&J Vaccine With ETFs

On Feb 27, the United States sanctioned Johnson & Johnson's COVID-19 vaccine for emergency use, giving the nation a third vaccine to fight the outbreak, after BioNTech/Pfizer and Moderna.

JNJ : 163.79 (+1.12%)
XLV : 124.71 (+0.78%)
JETS : 25.63 (+1.63%)
MNA : 33.45 (+0.10%)
IHE : 186.18 (+0.82%)
VOE : 140.43 (+2.04%)
IAT : 56.57 (+2.93%)
Pharma ETFs in Focus Post Q4 Earnings

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

JNJ : 163.79 (+1.12%)
PFE : 39.40 (+1.52%)
MRK : 76.62 (+0.01%)
LLY : 221.78 (+1.48%)
BMY : 66.62 (+0.23%)
PPH : 73.02 (+0.66%)
PJP : 80.69 (+0.52%)
IHE : 186.18 (+0.82%)
XPH : 52.48 (+1.04%)
FTXH : 25.85 (-0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Top 10 Holdings

Key Turning Points

3rd Resistance Point 187.26
2nd Resistance Point 186.68
1st Resistance Point 185.67
Last Price 186.18
1st Support Level 184.08
2nd Support Level 183.50
3rd Support Level 182.49

See More

52-Week High 189.58
Last Price 186.18
Fibonacci 61.8% 174.66
Fibonacci 50% 170.05
Fibonacci 38.2% 165.44
52-Week Low 150.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar